Last reviewed · How we verify
Hemoglobin SS disease with crisis
Approved treatments
- Hydroxycarbamide · University of Birmingham
- Siklos · Theravia
- Xromi · Nova Laboratories Limited
- Hydroxycarbamid · Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Hemoglobin SS disease with crisis patent landscape — cliff calendar, originator estates, attackable patents
- Hemoglobin SS disease with crisis treatment landscape brief
- Hemoglobin SS disease with crisis treatment updates RSS
Frequently asked questions about Hemoglobin SS disease with crisis
What drugs treat Hemoglobin SS disease with crisis?
Tracked treatments include Hydroxycarbamide, Siklos, Xromi, Hydroxycarbamid.
What is the treatment for Hemoglobin SS disease with crisis?
Standard treatment for Hemoglobin SS disease with crisis includes Hydroxycarbamide, Siklos, Xromi, Hydroxycarbamid. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Hemoglobin SS disease with crisis patent cliff · Hemoglobin SS disease with crisis CI report
- Treatment: Hydroxycarbamide · University of Birmingham
- Treatment: Siklos · Theravia
- Treatment: Xromi · Nova Laboratories Limited
- Treatment: Hydroxycarbamid · Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing